These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 37993867
1. Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis. Li G, Yan X. J Orthop Surg Res; 2023 Nov 22; 18(1):890. PubMed ID: 37993867 [Abstract] [Full Text] [Related]
2. HOTAIR Promotes Cisplatin Resistance of Osteosarcoma Cells by Regulating Cell Proliferation, Invasion, and Apoptosis via miR-106a-5p/STAT3 Axis. Guo J, Dou D, Zhang T, Wang B. Cell Transplant; 2020 Nov 22; 29():963689720948447. PubMed ID: 32757663 [Abstract] [Full Text] [Related]
3. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma. Xie X, Liu W, Duan Z, Li X, Zhang L, Yang G. Cell Mol Biol (Noisy-le-grand); 2020 Jun 05; 66(3):143-148. PubMed ID: 32538761 [Abstract] [Full Text] [Related]
4. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p. Cheng FH, Zhao ZS, Liu WD. Eur Rev Med Pharmacol Sci; 2019 Sep 05; 23(17):7256-7265. PubMed ID: 31539112 [Abstract] [Full Text] [Related]
5. Long non-coding RNA long intergenic non-coding 00641 mediates cell progression with stimulating cisplatin-resistance in osteosarcoma cells via microRNA-320d/myeloid cell leukemia-1 axis. Tang J, Zhu Z, Dong S, Wang Y, Wang J, Chen H, Duan G. Bioengineered; 2022 Mar 05; 13(3):7238-7252. PubMed ID: 35266447 [Abstract] [Full Text] [Related]
6. Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p. Sun G, Tian J, Xiao Y, Zeng Y. Anticancer Drugs; 2023 Aug 01; 34(7):816-826. PubMed ID: 36728962 [Abstract] [Full Text] [Related]
7. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p. Cao S, Fu B, Cai J, Zhang D, Wang C, Wu H. Cell Biol Toxicol; 2023 Apr 01; 39(2):483-496. PubMed ID: 35088190 [Abstract] [Full Text] [Related]
8. LncRNA SNHG12 Decreases Non-Small Cell Lung Cancer Cell Sensitivity to Cisplatin by Repressing miR-525-5p and Promoting XIAP. Tan D, Wang S, Zhang P, Peng C, Wu T. Ann Clin Lab Sci; 2023 Jan 01; 53(1):64-75. PubMed ID: 36889771 [Abstract] [Full Text] [Related]
9. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. Long X, Song K, Hu H, Tian Q, Wang W, Dong Q, Yin X, Di W. J Exp Clin Cancer Res; 2019 Aug 07; 38(1):345. PubMed ID: 31391118 [Abstract] [Full Text] [Related]
10. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p. Wang L, Wang D, Xu Z, Qiu Y, Chen G, Tan F. Thorac Cancer; 2023 Jul 07; 14(20):1946-1957. PubMed ID: 37277864 [Abstract] [Full Text] [Related]
11. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis. Wang J, Jia J, Zhou L. Neoplasma; 2020 Nov 07; 67(6):1279-1292. PubMed ID: 32787433 [Abstract] [Full Text] [Related]
12. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Zhang L, Zhao G, Ji S, Yuan Q, Zhou H. Med Sci Monit; 2020 Mar 10; 26():e921594. PubMed ID: 32155139 [Abstract] [Full Text] [Related]
13. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1. Zhang Y, Ai H, Fan X, Chen S, Wang Y, Liu L. Biol Res; 2020 Apr 29; 53(1):18. PubMed ID: 32349783 [Abstract] [Full Text] [Related]
14. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner. Gao Y, Huang Y. J Chemother; 2023 Apr 29; 35(2):117-130. PubMed ID: 35380509 [Abstract] [Full Text] [Related]
15. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2. Wu EY, Huang LP, Bao JH. Kaohsiung J Med Sci; 2022 Dec 29; 38(12):1178-1189. PubMed ID: 36354205 [Abstract] [Full Text] [Related]
16. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X. Exp Mol Pathol; 2021 Jun 29; 120():104633. PubMed ID: 33753110 [Abstract] [Full Text] [Related]
17. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis. Xie H, Yao J, Wang Y, Ni B. Drug Deliv; 2022 Dec 29; 29(1):1257-1271. PubMed ID: 35467477 [Abstract] [Full Text] [Related]
18. Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1. Ren A, Wen Z, Zheng L. Exp Ther Med; 2019 Sep 29; 18(3):1653-1660. PubMed ID: 31410122 [Abstract] [Full Text] [Related]
19. miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells. Gao S, Wang K, Wang X. Neoplasma; 2020 Jul 29; 67(4):724-734. PubMed ID: 32726125 [Abstract] [Full Text] [Related]
20. GAS5 alleviates cisplatin drug resistance in oral squamous cell carcinoma by sponging miR-196a. Yuan X, Jing Y, Guang M, Zhu J, Wang J, Wang Y, Zhang Y. J Int Med Res; 2022 Oct 29; 50(10):3000605221132456. PubMed ID: 36310502 [Abstract] [Full Text] [Related] Page: [Next] [New Search]